Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease

被引：0
|
作者：
Georgantas, Robert W. [1 ]
Bohana-Kashtan, Osnat [1 ]
Civin, Curt I. [1 ,2 ]
机构：
[1] Johns Hopkins, Div Immunol & Hematopoiesis, Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.1137
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1041
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [31] Serum levels of soluble fas ligand and TRAIL are associated with acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
    Wirth, C
    Schmid, C
    Adler, H
    Kolb, H
    BONE MARROW TRANSPLANTATION, 2005, 35 : S133 - S133
  • [32] Interferon gamma is required for Fas and Fas Ligand upregulation in acute graft vs host disease (GVHD).
    Shustov, A
    Nguyen, P
    Finkelman, F
    Elkon, K
    Via, C
    FASEB JOURNAL, 1998, 12 (04): : A584 - A584
  • [33] A major role for the fas pathway in acute graft-versus-host disease
    Via, CS
    Nguyen, P
    Shustov, A
    Drappa, J
    Elkon, KB
    JOURNAL OF IMMUNOLOGY, 1996, 157 (12): : 5387 - 5393
  • [34] MESENCHYMAL STEM CELLS IN THE TREATMENT OF REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
    Franco Villegas, A. Carolina
    Perez Corral, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S542 - S542
  • [35] Progressive accumulation of bacterial lipopolysaccharide in vivo during murine acute graft-versus-host disease
    Price, KS
    Nestel, FP
    Lapp, WS
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (03) : 294 - 300
  • [36] In vivo bioluminescence imaging of graft-versus-host disease after allogeneic bone marrow transplantation with ex vivo manipulated murine T cells.
    Rettig, MP
    Ritchey, JK
    Prior, JL
    Piwnica-Worms, D
    Bonyhadi, ML
    DiPersio, JF
    BLOOD, 2004, 104 (11) : 838A - 838A
  • [37] Ex vivo blockade of NF-κB signaling in alloreactive T cells prevents murine graft-versus-host disease (GVHD).
    O'Shaughnessy, MJ
    Vogtenhuber, C
    Serody, JS
    Sitcheran, R
    Baldwin, AS
    Dang, L
    Jaffee, B
    Blazar, BR
    BLOOD, 2004, 104 (11) : 835A - 835A
  • [38] Ex vivo blockade of NF-kB signaling in alloreactive T cells prevents murine graft-versus-host disease (GVHD)
    O'Shaughnessy, MJ
    Vogtenhuber, C
    Serody, J
    Sitcheran, R
    Baldwin, A
    Dang, L
    Adams, J
    Blazar, BR
    FASEB JOURNAL, 2003, 17 (07): : C60 - C60
  • [39] Depletion of naive lymphocytes with Fas-ligand ex vivo prevents graft-versus-host disease while maintaining T-cell support of engraftment and graft-versus-tumour activity
    Askenasy, N.
    Yaniv, I.
    Stein, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S253 - S253
  • [40] Prohibitin is Upregulated on Donor T cells in Murine Acute Graft-versus-Host Disease and Promotes Th17 Response
    Snyder, Katiri Jenna
    Gao, Yandi
    Neidemire-Colley, Lotus M.
    Sell, Natalie
    Ranganathan, Parvathi
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
12345